Advances in the Treatment of Head & Neck Cancer

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with recurring and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) by accelerating adoption of new guidelines ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with recurring and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Outline the mechanisms of action of PD-1 and PD-L1 blockade in SCCHN with high mutational burden and implication of immune resistance in SCCHNEvaluate PD-1/PD-L1 interactions through nivolumab and pembrolizumab that contribute to better outcomes for patients with SCCHN

---

1 Review

Resource tags